Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | HRH2 | P25021 | 12/20 | 0.39 |
| ▸ | HRH1 | P35367 | 12/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.34 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.34 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.34 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.34 |
| ▸ | DRD3 | P35462 | 2/20 | 0.34 |
| ▸ | DRD2 | P14416 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | HTR4 | Q13639 | 1/20 | 0.34 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20857025 | 0.80 | CYP2C19 (0.48) | CYP2C19HRH2HRH1TSHRDRD3 | |
| SCHEMBL22287259 | 0.80 | CYP2C19 (0.43) | CYP2C19HRH2HRH1TSHRDRD3 | |
| SCHEMBL29108908 | 0.77 | DRD3 (0.51) | DRD3DRD2USP2 | |
| SCHEMBL21078258 | 0.74 | HTR1A (0.46) | CYP2C19HRH1TSHRDRD3 | |
| SCHEMBL9980789 | 0.74 | ALDH1A1 (0.49) | CYP2C19TSHRCHRNB2CHRNA4DRD3 | |
| SCHEMBL20857027 | 0.72 | CYP2C19 (0.61) | CYP2C19TSHRLMNAUSP2 | |
| SCHEMBL29025304 | 0.71 | ALDH1A1 (0.41) | CYP2C19TSHRCHRNB2CHRNA4LMNA | |
| SCHEMBL11344621 | 0.71 | USP2 (0.45) | USP2 | |
| SCHEMBL167666 | 0.70 | L3MBTL1 (0.52) | HRH2HRH1TSHRDRD3 | |
| SCHEMBL7503597 | 0.70 | SLC6A3 (0.44) | CYP2C19HRH1TSHRDRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117417281-A | Anti-inflammatory, anti-cancer and anti-angiogenic compounds, pharmaceutical compositions and methods of making and using the same | 麦迪康制药公司 | 2024-01-19 | — | — | CN | disclosed |
| CN-111655666-B | Anti-inflammatory, anti-cancer and anti-angiogenic compounds, pharmaceutical compositions and methods of making and using the same | 麦迪康制药公司 | 2023-11-07 | — | — | CN | disclosed |
| CN-111655666-A | Anti-inflammatory, anti-cancer and anti-angiogenic compounds, pharmaceutical compositions and methods of making and using the same | 麦迪康制药公司 | 2020-09-11 | — | — | CN | disclosed |